Among 65 evaluable patients with sufficient tumour samples for NGS, the most frequent concomitant gene mutations were p53 (49%), MDM2 (25%), and POT1 (in 8 pts with sarcomatoid histologies). Here, MDM2 is linked to neoplasm.